Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Allen

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Journal of Clinical Microbiology|May 1, 1991
Evaluation of the new RapID-ANA II system for the identification of clinical anaerobic isolatesL M Marler, J A Siders, L C Wolters, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality controlR N Jones, A L Barry, M Pfaller, et al.
Journal of Clinical Microbiology|January 1, 1997
Rapid and effective method for preparation of fecal specimens for PCR assaysQ Lou, S K Chong, J F Fitzgerald, et al.
Journal of Clinical Microbiology|January 1, 1989
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory StandardsA L Barry, P C Fuchs, S D Allen, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1996
Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116))D L Sewell, A L Barry, S D Allen, et al.
The Journal of Infectious Diseases|October 1, 1978
Diagnosis and etiology of nongonococcal urethritisS L Swartz, S J Kraus, K L Herrmann, et al.
Journal of Clinical Microbiology|September 1, 1986
Volume of blood submitted for culture from neonatesP R Neal, M B Kleiman, J K Reynolds, et al.
Arzneimittel-Forschung|February 1, 1990
Studies on antifungal agents. Novel cis-5-alkyl (or alkenyl)-3-phenyl-3-(1H-azol-1-ylmethyl)-2-methyl-isoxazolidine derivativesG A Bennett, P A Swift, G B Mullen, et al.
Arzneimittel-Forschung|January 1, 1990
Studies on antifungal agents. In vitro activity of novel cis-5-alkoxy (or acyloxy)alkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine derivativesD M Maryniak, G B Mullen, S D Allen, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1993
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centersH S Sader, R N Jones, S D Allen, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Journal of Clinical Microbiology|May 1, 1991
Evaluation of the new RapID-ANA II system for the identification of clinical anaerobic isolatesL M Marler, J A Siders, L C Wolters, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality controlR N Jones, A L Barry, M Pfaller, et al.
Journal of Clinical Microbiology|January 1, 1997
Rapid and effective method for preparation of fecal specimens for PCR assaysQ Lou, S K Chong, J F Fitzgerald, et al.
Journal of Clinical Microbiology|January 1, 1989
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory StandardsA L Barry, P C Fuchs, S D Allen, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1996
Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116))D L Sewell, A L Barry, S D Allen, et al.
The Journal of Infectious Diseases|October 1, 1978
Diagnosis and etiology of nongonococcal urethritisS L Swartz, S J Kraus, K L Herrmann, et al.
Journal of Clinical Microbiology|September 1, 1986
Volume of blood submitted for culture from neonatesP R Neal, M B Kleiman, J K Reynolds, et al.
Arzneimittel-Forschung|February 1, 1990
Studies on antifungal agents. Novel cis-5-alkyl (or alkenyl)-3-phenyl-3-(1H-azol-1-ylmethyl)-2-methyl-isoxazolidine derivativesG A Bennett, P A Swift, G B Mullen, et al.
Arzneimittel-Forschung|January 1, 1990
Studies on antifungal agents. In vitro activity of novel cis-5-alkoxy (or acyloxy)alkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine derivativesD M Maryniak, G B Mullen, S D Allen, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1993
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centersH S Sader, R N Jones, S D Allen, et al.
Pageof 15